Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1444186PMC
http://dx.doi.org/10.1136/bmj.288.6410.68-bDOI Listing

Publication Analysis

Top Keywords

treatment asthma
4
asthma promotional
4
promotional expediency
4
expediency versus
4
versus pharmaceutical
4
pharmaceutical responsibility
4
treatment
1
promotional
1
expediency
1
versus
1

Similar Publications

This report details a case study of a non-smoking 33-year-old female nurse who developed occupational asthma as an Inside Attendant (IA) in a hyperbaric chamber. The report analyzes the nurse's medical history, working environment, and potential causes. After beginning work in the hyperbaric chamber, an IA experienced respiratory symptoms, including coughing, wheezing, and fatigue.

View Article and Find Full Text PDF

Parosmia: Pathophysiology and Management.

Curr Allergy Asthma Rep

January 2025

Smell and Taste Clinic, Department of Otorhinolaryngology, Technical University of Dresden, Dresden, Germany.

Purpose Of Review: Parosmia is a qualitative olfactory disorder in which there is a mismatch between the memory of an odor and the actual experience triggered by an odor. There has been a surge in parosmia-related publications since the COVID-19 pandemic. This review summarizes the latest clinical findings, theories on pathophysiology and potential treatment options.

View Article and Find Full Text PDF

Aims: Asthma is characterized by chronic airway inflammation, persistent cough, wheezing, and dyspnea. This study aimed to evaluate the efficacy of Limosilactobacillus reuteri VHProbi® M07 (M07) administration in alleviate the asthma severity in a mice model.

Methods And Results: In vitro studies confirmed that M07 can survive and proliferate within the gastrointestinal tract.

View Article and Find Full Text PDF

Background: Chronic obstructive pulmonary disease (COPD), congestive heart failure (CHF), and acute pulmonary edema (APE) are serious illnesses that often require acute care from prehospital emergency medical services (EMSs). These respiratory diseases that cause acute respiratory failure (ARF) are one of the main reasons for hospitalization and death, generating high health care costs. The prevalence of the main respiratory diseases treated in a prehospital environment in the prepandemic period and during the COVID-19 pandemic in Spain is unknown.

View Article and Find Full Text PDF

Background: Prevalence of potential drug-drug interactions (pDDIs) in adult patients with severe asthma on biological therapy and their clinical significance have not been fully addressed, thus the aim of this study was to investigate them.

Methods: In this retrospective observational study, patients who were diagnosed with severe asthma and to whom biological therapy was prescribed between September 2015 and December 2020, were enrolled. The study was conducted at the Department of Allergic and Obstructive Pulmonary Diseases, Clinic for Lung Diseases Jordanovac, Clinical Hospital Center Zagreb.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!